Clinical Trials Browser

Phase NA × Terminated × Magnetic Resonance Spectroscopy × Clear all

NCT06315296 2026-03-03

An Interactive Time-Restricted Diet Intervention (txt4fasting) for Reducing Neurocognitive Decline and Improving Survival in Patients With Brain Metastases From Breast or Lung Cancer

Phase NA Terminated

BreastCNSThoracic

Brain Neoplasms, Breast Neoplasms, Lung Neoplasms

NCT04831138 2025-12-19

Non-Contrast Perfusion Using Arterial Spin Labeled MR Imaging for Assessment of Therapy Response in Metastatic Renal Cell Carcinoma

Phase NA Terminated

6 enrolled 7 charts

Carcinoma, Renal Cell

NCT04493411 2025-07-24

Noninvasive Detection and Assessment of Therapy Response in Multiple Myeloma Using Whole-Body MRI

Phase NA Terminated

Multiple Myeloma

NCT01243333 2024-04-17

Multi-Tracer Positron Emission Tomography in Patients With Solid Tumors

Phase NA Terminated

26 enrolled 11 charts

Neoplasms

NCT01712815 2023-08-14

PET/CT in Evaluating Response to Chemotherapy in Patients With Breast Cancer

Phase NA Terminated

Breast Neoplasms

NCT02445456 2022-07-06

SentiRect

Phase NA Terminated

15 enrolled 14 charts

Gastrointestinal

Rectal Neoplasms

NCT02149173 2021-06-30

F-18 FES PET/CT in Measuring Hormone Expression in Patients With Primary, Recurrent, or Metastatic Breast Cancer Undergoing Endocrine-Targeted Therapy

Phase NA Terminated

29 enrolled 9 charts

Breast Neoplasms

NCT02966223 2020-09-25

A Study to Assess the Effect of Y-90 Therapy on Non-target/Background Liver

Phase NA Terminated

20 enrolled 4 charts

Gastrointestinal

Liver Neoplasms

NCT00444223 2020-08-05

Fluorine F 18 FEQA in Patients With Stage III or Stage IV Non-Small Cell Lung Cancer and in Healthy Participants

Phase NA Terminated

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT02121600 2019-05-07

18F-FCH PET/MRI to Assess Tumor Response in Castration Resistant Prostate Cancer

Phase NA Terminated

Prostatic Neoplasms

NCT01502228 2019-03-05

PET/CT Assessment of Tumor Perfusion in Patients With Renal Cell Carcinoma

Phase NA Terminated

14 enrolled 7 charts

Carcinoma, Renal Cell

NCT01263821 2017-08-04

Image Guided Therapy in the Treatment of Gliomas

Phase NA Terminated

Glioma

NCT01541358 2017-06-14

Sodium Fluoride PET/CT for the Evaluation of Skeletal Cancer

Phase NA Terminated

2 enrolled 8 charts

Bone Neoplasms

NCT01882231 2017-05-08

Quantitative Imaging Biomarkers of Treatment Response in Osteosarcoma and Ewing Sarcoma

Phase NA Terminated

Bone Neoplasms, Osteitis Deformans, Sarcoma, Ewing, Osteosarcoma

NCT01246726 2016-11-15

MOSS

Phase NA Terminated

Breast Neoplasms, Neoplasms

NCT01761812 2016-10-18

Multiparametric MRI for Prostate Cancer Localization and Characterization: New Methods

Phase NA Terminated

Prostatic Neoplasms

NCT00429338 2015-01-09

3T Endorectal Magnetic Resonance Spectroscopic Imaging (MRSI) of Prostate

Phase NA Terminated

Prostatic Neoplasms

NCT00504205 2013-08-02

MP470 in Treating Patients With Unresectable or Metastatic Solid Tumor or Lymphoma

Phase NA Terminated

DermatologicLymphoidOther hematologic neoplasm

Burkitt Lymphoma, Hodgkin Disease, Immunoblastic Lymphadenopathy, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Mycosis Fungoides, Sezary Syndrome, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Intraocular Lymphoma

NCT00147238 2012-08-07

A Validation Study of MR Lymphangiography Using SPIO, a New Lymphotropic Superparamagnetic Nanoparticle Contrast

Phase NA Terminated

10 enrolled 3 charts

Urinary Bladder Neoplasms, Prostatic Neoplasms, Urogenital Neoplasms